169 - Developing a Novel Chemical AI Platform to Discover New Doping Agents - Michael Skinnider, PhD
About this episode
Dr. Michael Skinnider discusses his research on a novel AI platform for discovering new doping agents.
Dr. Michael Skinnider is an Assistant Professor in the Ludwig Princeton Branch of the Ludwig Institute for Cancer Research and the Lewis-Sigler Institute for Integrative Genomics at Princeton University. In this interview, Mike discusses how he got involved in anti-doping research and provides an in-depth look into the novel chemical artificial intelligence (AI) platform he has been developing that is focused on discovering new doping agents. He shares next steps for this line of research and his perspective on the potential impacts of this work for the anti-doping community.
More episodes of The Anti-Doping Podcast
- 176 - Protecting the Podium and Building Trust in Athletics Through Anti-Doping Efforts - Brett Clothier
- 175 - Investigating Potential Confounding Factors for Doping Analysis and the Athlete Biological Passport - Sara Solheim, PhD
- 174 - Developing New Approaches to Address Bias and Improve Doping Prevalence Estimates - Maarten Cruyff, PhD
- 173 - Sharing Her Story of Competition, Courage, and Clean Sport - Kara Goucher, OLY
- 172 - FIFA's Role in Supporting Player Health, Clean Competition, and Sport Integrity in Soccer - Carlos López Tiboni
- 171 - Strengthening Ethics and Compliance Accountability in U.S. Olympic and Paralympic Communities - Holly Shick, JD
Explore listener stats, chart rankings, contacts and more on the The Anti-Doping Podcast podcast page.